WFDC12 and dry eye syndrome: In vitro experiments demonstrated the regulatory pathway or axis of WFDC12 using potential gene dysfunction in KCs. Although omics studies have shown that the retinoic acid pathway may be one of the pathways of action of WFDC12, we will further verify the expression of other pathways in KCs, such as immunity, protein folding, proliferation, and apoptosis.